Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Samsung BioLogics will spend $730 million to build a biologics facility at its site in Songdo, South Korea. The new plant, the company’s third, will feature 180,000 L of fermentation capacity for mammalian-cell-culture-based biologics. Samsung BioLogics employs 1,000 people and expects its headcount will rise to 1,800 in 2018 when the plant comes on-line. The contract manufacturer is majority-owned by Samsung Electronics and other Samsung firms.
This article has been sent to the following recipient: